Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer

Clinical trial NCT05215379 · COMPLETED

Trial details

NCT number: NCT05215379
Sponsor: Changhai Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Neoadjuvant Chemoradiation Therapy Rectal Cancer Immunotherapy Microsatellite Instability Low

Start date: 2022-10-01
Primary completion: 2024-12-30
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.